Search Results
Jul 06, 2026, 14:31 ET Immutep Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - IMMP
2026CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Immutep filed an SEC Form-K on January 30, 2026 that its TACTI-004 trial of eftilagimod alfa ("efti") was showing "strong operational progress." Despite this claim, the Company knew
More news about: DJS Law Group LLP
Jul 06, 2026, 14:20 ET IMMP Investors Have Opportunity to Lead Immutep Limited Securities Fraud Lawsuit with the Schall Law Firm
misleading statements to the market. Immutep concealed the results of its TACTI-004 trial of eftilagimod alfa's ("efti"). The Company claimed in a Form-K filed with the SEC on January 30, 2026, that the trial was demonstrating "strong operational progress." The Company was aware at that time that the TACTI-004
More news about: The Schall Law Firm
Jul 06, 2026, 14:06 ET /C O R R E C T I O N -- Bitmine Immersion Technologies, Inc./
Bedingungen, von denen viele außerhalb der Kontrolle von Bitmine liegen, einschließlich derjenigen, die im Abschnitt „Risikofaktoren" des Formulars 10-K von Bitmine aufgeführt sind, das am 21. November 2025 bei der SEC eingereicht wurde, sowie allen anderen bei der SEC eingereichten Unterlagen, die von
More news about: Bitmine Immersion Technologies, Inc.
Jul 06, 2026, 13:45 ET AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma
technological and other factors that may affect AbbVie's operations is set forth in Item 1A, "Risk Factors," of AbbVie's 2025 Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as updated by its Quarterly Reports on Form 10-Q and in other documents that AbbVie
More news about: AbbVie
Jul 06, 2026, 13:45 ET AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma
technological and other factors that may affect AbbVie's operations is set forth in Item 1A, "Risk Factors," of AbbVie's 2025 Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as updated by its Quarterly Reports on Form 10-Q and in other documents that AbbVie
More news about: AbbVie
Jul 06, 2026, 12:09 ET TMRW Vault® získava označenie CE podľa európskeho nariadenia o zdravotníckych pomôckach (MDR)
zariadení CryoBeacons s podporou technológie RFID a softvéru ivfOS®, ktoré digitálne overujú identitu a polohu vzorky.Manuálny prístup k technologicky vyspelej nádrži zariadenia Vault, čo umožňuje embryológom efektívne skladovať a vyberať vzorky a zároveň zachovať úplnú digitálnu sledovateľnosť.Pokročilé
More news about: Reprotech, LLC
Jul 06, 2026, 12:00 ET SIRUI Releases Three New Lightweight Full-Frame Cine Primes for Vision Prime Series: 15mm T1.6, 75mm T1.4, 150mm T4 (1.5x Macro)
and HRI high-refractive glass elements. This compact optical layout suppresses distortion and chromatic aberration, delivering sharp resolution for 8K and higher resolution workflows. Minimal focus breathing and excellent distortion control align with professional cinema standards for seamless focus
More news about: SIRUI
Jul 06, 2026, 11:59 ET Spoločnosť SINEXCEL na veľtrhu Intersolar Europe 2026 rozširuje európsky ekosystém skladovania energie a posilňuje tak svoj dlhodobý záväzok voči Európe
SINEXCEL (300693.SZ) prehĺbila svoj dlhodobý záväzok voči európskemu trhu uvedením svojho systému premeny energie (PCS) pre veľké siete, StellaON 1250K/1575K, ktorý integruje zariadenia Infineon, spolu so sériou strategických partnerstiev posilňujúcich lokalizované možnosti dodržiavania predpisov, služieb
More news about: SINEXCEL
Jul 06, 2026, 11:57 ET SINEXCEL étend son écosystème européen de stockage d'énergie lors du salon Intersolar Europe 2026, renforçant ainsi son engagement à long terme vis-à-vis de l'Europe
échelle nouvelle génération en EuropeConçue pour le marché européen du stockage d'énergie en pleine évolution, la solution StellaON 1250K/1575K répond aux exigences croissantes du secteur en matière de résilience environnementale, d'adaptabilité au réseau et d'efficacité tout au long du cycle
More news about: SINEXCEL
Jul 06, 2026, 11:50 ET Allstate to hold Q2 2026 earnings call Aug. 6, 2026
www.allstateinvestors.comFinancial Results Release (Form 8-K)Allstate will file its Q2 2026 financial results via a Form 8-K with the Securities and Exchange Commission (SEC) after 4:15 p.m. ET on Wednesday, August 5, 2026. The
More news about: Allstate Insurance Company
Jul 06, 2026, 11:16 ET /C O R R E C C I O N -- Bitmine Immersion Technologies, Inc./
numerosas condiciones, muchas de las cuales escapan al control de Bitmine, incluidas las establecidas en la sección de Factores de Riesgo del Formulario 10-K de Bitmine presentado ante la SEC el 21 de noviembre de 2025, así como en todos los demás documentos presentados ante la SEC, según se modifiquen o actualicen
More news about: Bitmine Immersion Technologies, Inc.
Jul 06, 2026, 10:31 ET Fuchs Endothelial Corneal Dystrophy Market Forecast Highlights Significant Growth During the Forecast Period (2026-2036), Owing to the Expanding Treatment Landscape and Increasing Patient Pool | DelveInsight
under development include Ripasudil (K-321) (Kowa Pharmaceuticals), TTHX1114 (Trefoil Therapeutics), STN1010904/AE-001 (sirolimus) (Santen/ActualEyes), DT-168 (Design Therapeutics), and others.Kowa Pharmaceuticals' Ripasudil (K-321) is a selective Rho-associated protein
More news about: DelveInsight Business Research, LLP
Jul 06, 2026, 10:30 ET /C O R R E C T I O N -- Bitmine Immersion Technologies, Inc./
subject to numerous conditions, many of which are beyond Bitmine's control, including those set forth in the Risk Factors section of Bitmine's Form 10-K filed with the SEC on November 21, 2025, as well as all other SEC filings, as amended or updated from time to time. Copies of Bitmine's filings with the
More news about: Bitmine Immersion Technologies, Inc.
Jul 06, 2026, 10:15 ET /C O R R E C T I O N -- Bitmine Immersion Technologies, Inc./
subject to numerous conditions, many of which are beyond Bitmine's control, including those set forth in the Risk Factors section of Bitmine's Form 10-K filed with the SEC on November 21, 2025, as well as all other SEC filings, as amended or updated from time to time. Copies of Bitmine's filings with the
More news about: Bitmine Immersion Technologies, Inc.
Jul 06, 2026, 10:11 ET SINEXCEL запускает StellaON 1250K/1575K для продвижения энергосбережения в Европе
6 июля 2026 г. /PRNewswire/ -- На выставке Intersolar Europe 2026 компания SINEXCEL (300693.SZ) представила систему StellaON 1250K/1575K PCS, интегрирующую устройства Infineon для удовлетворения растущих потребностей Европы в экологической устойчивости, стабильности энергосистемы
More news about: SINEXCEL
Jul 06, 2026, 10:03 ET Argosy Charts a New Route with K&L Freight Acquisition
K&L Freight Management ("K&L" or the "Company"), an asset-light third-party logistics ("3PL") provider. K&L specializes in time-sensitive, mission-critical freight services for the Food & Beverage,
More news about: Argosy Private Equity
Jul 06, 2026, 10:00 ET French orthopedic pioneer Movmedix enters the United States following FDA clearance of LARS® Technology
orthopedic MedTech company behind the internationally recognized LARS® synthetic ligament platform, today announced that it has received its first 510(k) U.S. Food and Drug Administration (FDA) clearance, enabling the commercial launch of its LARS® ACJ system in the United States.
More news about: MOVMEDIX
Jul 06, 2026, 09:30 ET 3M Young Scientist Challenge Names 10 Finalists for 2026 National Competition
learning. Discovery Education's solutions have served more than 100 million students globally, supporting effective teaching and learning in 45% of U.S. K-12 schools and in 100+ countries and territories. The company's portfolio includes award-winning core and supplemental curriculum, high-quality standards-aligned
More news about: 3M Company
Jul 06, 2026, 09:30 ET Curis Consents First Six Patients in TakeAim CLL Study
indicated by forward-looking statements include the factors set forth under the captions "Risk Factor Summary" and "Risk Factors" in our most recent Form 10-K, and the factors that are discussed in other filings that Curis periodically makes with the Securities and Exchange Commission. In addition, any forward-looking
More news about: Curis, Inc.
Jul 06, 2026, 09:25 ET ExhVerse Launches a Free Online Art Gallery Platform for Immersive Virtual Exhibitions
complete, shareable 3D show at no cost. Creators who need more can upgrade to an affordable Pro plan for up to 30 exhibitions, 200 artworks per exhibition, 4K Ultra HD presentation, video uploads, and logo-free galleries, backed by a 7-day money-back guarantee.By presenting work inside immersive 3D spaces
More news about: ExhVerse
Jul 06, 2026, 09:25 ET Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
materially from those anticipated in forward-looking statements can be found under the caption "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended March 31, 2026, and in the Company's other filings with the Securities and Exchange Commission, including its quarterly Reports on
More news about: Aethlon Medical, Inc.
Jul 06, 2026, 09:00 ET EdTech Quality Collaborative Launches New Guide to Help School Districts Streamline Procurement and Reduce Administrative Burden
A unified initiative by 1EdTech, CAST, CoSN, Digital Promise, ISTE, and SETDA to operationalize product quality standards in K-12 educationWASHINGTON, July 6, 2026 /PRNewswire/ -- To equip school
More news about: Digital Promise
Jul 06, 2026, 09:00 ET SuperCom wins New Electric Monitoring Contract in Michigan Expanding U.S. Presence into 18th New State
20-F for the year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission (the "SEC") on April 28, 2026, our reports on Form 6-K filed from time to time with the SEC and our other filings with the SEC. Except as required by law, we do not undertake any obligation to update or revise
More news about: SuperCom
Jul 06, 2026, 09:00 ET New Research Reveals AI Use Has Reached a Tipping Point in Higher Education
Find out how D2L helps transform lives and delivers outstanding learning outcomes in K-12, higher education and businesses.X: @D2L© 2026 D2L Corporation.The D2L family of companies includes D2L Inc., D2L Corporation,
More news about: D2L
Jul 06, 2026, 09:00 ET KAYALI Launches Boujee Kitty Caramel Milk | 22 Eau de Parfum, a New Gourmand Fragrance Created by Mona Kattan
(@broderickhunter), Amy K
More news about: KAYALI